» Articles » PMID: 7833626

Expression and Functional Role of Dipeptidyl Peptidase IV (CD26) on Human Natural Killer Cells

Overview
Journal Nat Immun
Date 1994 Sep 1
PMID 7833626
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The expression and functional role of dipeptidyl peptidase IV (DP IV, CD26, EC 3.4.14.5) was studied on human natural killer (NK) cells. Here we show that freshly isolated NK cells do express only low amounts of DP IV. However, after IL-2 stimulation of NK cells (70% purity) surface DP IV expression was significantly increased in a subpopulation (30%) of these cells. Specific DP IV inhibitors (Lys-[Z-(NO2)]-piperidide, Lys-[Z(NO2)]-thiazolidide) and polyclonal antibodies directed against the ectopeptidase suppressed DNA synthesis and cell cycle progression of NK cells. The natural cytotoxic activity of DP IV+ CD56+ cells was found unchanged in comparison to those of DP IV- CD56+ cells. DP IV inhibitors had no effect on the natural cytotoxicity of mononuclear cells. From these data we conclude that DP IV is involved in the regulation of proliferation of NK cells, whereas natural cytotoxicity seems to be regulated independently.

Citing Articles

Contribution of amino acids in the active site of dipeptidyl peptidase 4 to the catalytic action of the enzyme.

Gnoth K, Bar J, Rosche F, Rahfeld J, Demuth H PLoS One. 2024; 19(4):e0289239.

PMID: 38625918 PMC: 11020753. DOI: 10.1371/journal.pone.0289239.


Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention.

Laeeq T, Ahmed M, Sattar H, Zeeshan M, Ali M Cancers (Basel). 2024; 16(7).

PMID: 38611003 PMC: 11011099. DOI: 10.3390/cancers16071325.


Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors.

Rahim K, Shan M, Ul Haq I, Nawaz M, Maryam S, Alturki M J Inflamm Res. 2024; 17:1897-1917.

PMID: 38544813 PMC: 10968008. DOI: 10.2147/JIR.S442106.


Depletion of polyfunctional CD26CD8 T cells repertoire in chronic lymphocytic leukemia.

Bozorgmehr N, Hnatiuk M, Peters A, Elahi S Exp Hematol Oncol. 2023; 12(1):13.

PMID: 36707896 PMC: 9881277. DOI: 10.1186/s40164-023-00375-5.


New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors.

Cui C, Tian X, Wei L, Wang Y, Wang K, Fu R Front Pharmacol. 2022; 13:1002871.

PMID: 36172198 PMC: 9510841. DOI: 10.3389/fphar.2022.1002871.